These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 21310918)

  • 1. A potential role for angiopoietin 2 in the regulation of the blood-retinal barrier in diabetic retinopathy.
    Rangasamy S; Srinivasan R; Maestas J; McGuire PG; Das A
    Invest Ophthalmol Vis Sci; 2011 Jun; 52(6):3784-91. PubMed ID: 21310918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Erythropoietin maintains VE-cadherin expression and barrier function in experimental diabetic retinopathy via inhibiting VEGF/VEGFR2/Src signaling pathway.
    Liu D; Xu H; Zhang C; Xie H; Yang Q; Li W; Tian H; Lu L; Xu JY; Xu G; Liu K; Sun X; Xu GT; Zhang J
    Life Sci; 2020 Oct; 259():118273. PubMed ID: 32800831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic regulation of VE-cadherin with a novel oligonucleotide drug for diabetic eye complications using retinopathy mouse models.
    Ting KK; Zhao Y; Shen W; Coleman P; Yam M; Chan-Ling T; Li J; Moller T; Gillies M; Vadas MA; Gamble JR
    Diabetologia; 2019 Feb; 62(2):322-334. PubMed ID: 30443753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The cKit Inhibitor, Masitinib, Prevents Diabetes-Induced Retinal Vascular Leakage.
    Kim SR; Im JE; Jeong JH; Kim JY; Kim JT; Woo SJ; Sung JH; Park SG; Suh W
    Invest Ophthalmol Vis Sci; 2016 Mar; 57(3):1201-6. PubMed ID: 26978025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. VEGF-B prevents chronic hyperglycemia-induced retinal vascular leakage by regulating the CDC42-ZO1/VE-cadherin pathway.
    Xu Y; Peng Y; Wu X; Ni F; Sun D; Zhang P; Yang Y; Yan M; Mi J; Tian G
    FASEB J; 2024 Sep; 38(17):e70019. PubMed ID: 39215561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simvastatin increases circulating endothelial progenitor cells and reduces the formation and progression of diabetic retinopathy in rats.
    Zhang W; Yan H
    Exp Eye Res; 2012 Dec; 105():1-8. PubMed ID: 23059402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beneficial effects of the Src inhibitor, dasatinib, on breakdown of the blood-retinal barrier.
    Kim SR; Suh W
    Arch Pharm Res; 2017 Feb; 40(2):197-203. PubMed ID: 27988882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteolytic degradation of VE-cadherin alters the blood-retinal barrier in diabetes.
    Navaratna D; McGuire PG; Menicucci G; Das A
    Diabetes; 2007 Sep; 56(9):2380-7. PubMed ID: 17536065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alterations in expression of angiopoietins and the Tie-2 receptor in the retina of streptozotocin induced diabetic rats.
    Ohashi H; Takagi H; Koyama S; Oh H; Watanabe D; Antonetti DA; Matsubara T; Nagai K; Arai H; Kita T; Honda Y
    Mol Vis; 2004 Aug; 10():608-17. PubMed ID: 15354084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperglycemia-induced effects on glycocalyx components in the retina.
    Kaur G; Rogers J; Rashdan NA; Cruz-Topete D; Pattillo CB; Hartson SD; Harris NR
    Exp Eye Res; 2021 Dec; 213():108846. PubMed ID: 34801534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of hyperglycaemia on permeability and the expression of junctional complex molecules in human retinal and choroidal endothelial cells.
    Saker S; Stewart EA; Browning AC; Allen CL; Amoaku WM
    Exp Eye Res; 2014 Apr; 121():161-7. PubMed ID: 24594192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Downregulation of retinal GLUT1 in diabetes by ubiquitinylation.
    Fernandes R; Carvalho AL; Kumagai A; Seica R; Hosoya K; Terasaki T; Murta J; Pereira P; Faro C
    Mol Vis; 2004 Aug; 10():618-28. PubMed ID: 15359219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aquaporin 4 knockdown exacerbates streptozotocin-induced diabetic retinopathy through aggravating inflammatory response.
    Cui B; Sun JH; Xiang FF; Liu L; Li WJ
    Exp Eye Res; 2012 May; 98():37-43. PubMed ID: 22449442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A three-pore model describes transport properties of bovine retinal endothelial cells in normal and elevated glucose.
    Lopez-Quintero SV; Ji XY; Antonetti DA; Tarbell JM
    Invest Ophthalmol Vis Sci; 2011 Feb; 52(2):1171-80. PubMed ID: 21357410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood-retinal barrier breakdown induced by activation of protein kinase C via vascular endothelial growth factor in streptozotocin-induced diabetic rats.
    Xu X; Zhu Q; Xia X; Zhang S; Gu Q; Luo D
    Curr Eye Res; 2004 Apr; 28(4):251-6. PubMed ID: 15259294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. COMP-Ang1 Stabilizes Hyperglycemic Disruption of Blood-Retinal Barrier Phenotype in Human Retinal Microvascular Endothelial Cells.
    Rochfort KD; Carroll LS; Barabas P; Curtis TM; Ambati BK; Barron N; Cummins PM
    Invest Ophthalmol Vis Sci; 2019 Aug; 60(10):3547-3555. PubMed ID: 31415078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neutrophil elastase contributes to the pathological vascular permeability characteristic of diabetic retinopathy.
    Liu H; Lessieur EM; Saadane A; Lindstrom SI; Taylor PR; Kern TS
    Diabetologia; 2019 Dec; 62(12):2365-2374. PubMed ID: 31612267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Eucalyptol Ameliorates Retinal Microvascular Defects through Modulating ER Stress and Angiopoietin-Tie Signaling in Diabetic Eyes.
    Kim DY; Park SH; Yoon Z; Kim J; Kang MK; Kang YH
    Int J Mol Sci; 2024 Jul; 25(14):. PubMed ID: 39063066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Osteopontin-induced vascular hyperpermeability through tight junction disruption in diabetic retina.
    Someya H; Ito M; Nishio Y; Sato T; Harimoto K; Takeuchi M
    Exp Eye Res; 2022 Jul; 220():109094. PubMed ID: 35490836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of the blockade of the IL-23-Th17-IL-17A pathway on streptozotocin-induced diabetic retinopathy in rats.
    Xu H; Cai M; Zhang X
    Graefes Arch Clin Exp Ophthalmol; 2015 Sep; 253(9):1485-92. PubMed ID: 25371107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.